2,190 material Form 8-K filings that 1,874 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Datavault AI's board appointed Brett Moyer as Chief Executive Officer and President, effective immediately, after Nathaniel Bradley was removed from that role on November 1, 2026. Board changes also name Kimberly Briskey Chair and Teresa Gallo Chief Operating Officer, a shake-up that bears on how the company is run and governed.
Brett Moyer, previously CFO and a director, named CEO and President effective November 6, 2026; Nathaniel Bradley removed as CEO on November 1, 2026
Stanley Mbugua, previously Chief Accounting Officer, named Chief Financial Officer; Teresa Gallo named Chief Operating Officer
Kimberly Briskey named Chair of the Board; Christopher R. Hardt named Chair of the Audit Committee
Company says it will report third-quarter 2026 results on a date to be announced
Randolph C. Read resigned from the board of Roman DBDR Acquisition Corp. II, along with its audit and compensation committees, effective immediately, on November 4, 2026. The filing states his resignation was not due to any disagreement with the company on operations, policies or practices, and the board named Bryn Sherman and Hunter Gary to fill the committee vacancies.
Randolph C. Read resigned from the board, audit committee and compensation committee on November 4, 2026, effective immediately
Bryn Sherman appointed chairperson of the Compensation Committee, effective November 4, 2026
Hunter Gary appointed as a member of the Audit Committee, effective November 4, 2026
Filing states the resignation was not the result of any disagreement with the company
Mount Logan Capital appointed Brandon Harper as its Chief Accounting Officer and principal accounting officer, effective November 3, 2026. Brandon Satoren, the company's CFO, no longer serves as principal accounting officer, though he remains CFO.
Brandon Harper, age 33, appointed by the board on November 3, 2026, previously served as Group Controller from July 2026.
Harper received 7,080 restricted stock units on November 6, 2026, vesting in three equal installments on January 1, 2027, 2028 and 2029.
Brandon Satoren, Chief Financial Officer, no longer serves as principal accounting officer as of November 3, 2026.
The filing notes potential conflicts of interest with BC Partners Advisors L.P., the company's servicing agent and holder of a minority equity interest through an affiliate.
T3 Defense Inc. completed its acquisition of KeepZone AI Inc. on November 4, 2026, paying by issuing 425,594 shares of common stock to the seller, Nexera Technologies Ltd. An amendment to the purchase agreement raised the purchase price to $1,539,800 and lifted the seller's beneficial ownership limit in the company to 9.9%. The company said the deal was not a significant acquisition, so separate KeepZone financial statements are not required.
Purchase price raised to $1,539,800 under the amendment dated November 4, 2026
425,594 new common shares issued to Nexera Technologies Ltd. as consideration
Seller's beneficial ownership limit in T3 Defense raised to 9.9%
Company states the acquisition was not significant under Item 2.01 of Form 8-K
Shuttle Pharmaceuticals Holdings dismissed Forvis Mazars, LLP as its independent registered public accounting firm and engaged Bush & Associates CPA LLC on November 2, 2026. Bush & Associates will audit the fiscal year ending December 31, 2026, and review interim financial statements through September 30, 2027. The filing states no disagreements or reportable events with the former auditor.
Forvis Mazars dismissal was approved by the Audit Committee and full Board, effective after the Form 10-Q for the quarter ended September 30, 2026, as previously reported October 21, 2026.
Bush & Associates CPA LLC was engaged on November 2, 2026, under an engagement letter dated October 19, 2026.
Bush & Associates will audit fiscal 2026 and review interim quarters ending March 31, June 30 and September 30, 2027.
The company states there were no consultations with Bush & Associates on accounting matters and no disagreements or reportable events in fiscal 2024, fiscal 2025 or the interim period through November 2, 2026.
Mangoceuticals' sole Series B preferred holder approved terms for a new 8% Series D convertible cumulative preferred stock and an amendment to the Series B designation, which would allow the company to sell up to 1,000,000 shares at $10.00 each under Regulation A. The company said the instruments are not yet filed or effective and it may not proceed with the offering; the company also set its combined 2025 and 2026 annual meeting for December 30, 2026.
On November 2, 2026, the holder of all 50 outstanding Series B preferred shares approved the Series D terms and Series B amendment by written consent.
Proposed Series D offering: up to 1,000,000 shares at $10.00 per share under Regulation A; no sales will occur before the SEC qualifies the offering statement on Form 1-A.
Annual meeting set for December 30, 2026 in Dallas, Texas; record date is November 12, 2026.
Shareholder proposals and director nominations for the meeting are due by November 16, 2026.
BioVie Inc. agreed on November 3, 2026 to sell shares and pre-funded warrants in a registered direct offering and common warrants in a concurrent private placement, with aggregate gross proceeds of approximately $4.74 million before fees and expenses. The offering closed on November 5, 2026, and the company intends to use the net proceeds for working capital and general corporate purposes. The deal adds shares and dilutive warrants, and the company has agreed to restrictions on new share issuances.
Registered direct offering: 960,000 shares at $1.60 per share plus 2,002,500 pre-funded warrants at $1.5999 each
Concurrent private placement: 2,962,500 common warrants exercisable at $1.70 per share, starting six months after issuance
Placement agent A.G.P./Alliance Global Partners receives a cash fee of 7.0% of gross proceeds
Company and directors and officers agreed to issuance and sale restrictions for 60 days after the November 5, 2026 closing
Kontoor Brands completed the sale of its H.D. Lee Company subsidiary to ABG-Storm LLC, an affiliate of Authentic Brands Group, on November 2, 2026. The company received $750 million in cash at closing, subject to post-closing adjustments, plus up to $250 million in earnout payments tied to the Lee business's performance over five years. The filing says the company anticipates using $400 million for accelerated share repurchases and $50 million for open market repurchases.
Closing date: November 2, 2026; cash at closing of $750 million before post-closing adjustments
Pro forma estimate of cash received after adjustments: approximately $698.2 million
Earnout of up to $250 million over five years; estimated fair value at closing of $77.0 million
Planned use of proceeds: $400 million in accelerated share repurchases and $50 million in open market repurchases
HeartSciences filed an 8-K with supplemental disclosures to its proxy statement for the proposed merger with Fortitude Mining Holdings, a subsidiary of Digital Currency Group. The company received seven demand letters from purported shareholders alleging the proxy omits material information, and says the claims are without merit but is voluntarily adding disclosures to avoid delays and litigation expense. The special meeting remains scheduled for November 19, 2026, so the disclosures do not change the vote timing.
Seven demand letters received from counsel to purported shareholders alleging proxy omissions.
Company denies the allegations and says disclosures are voluntary, made without admitting liability.
Supplemental disclosures include a January 6, 2026 letter of intent with Fortitude and an indicated equity value range for Fortitude of $206.0 million to $428.2 million.
Special Meeting to be held virtually on November 19, 2026, at 10:00 a.m. Eastern Time.
First Breach announced a supplier agreement giving it the ability to purchase up to 20 million primers per month, two additional ammunition inspection units, and a separate raw material supply agreement. The company says these steps support plans to scale ammunition production toward up to 20 million rounds per month and move toward 24-hour operations.
Primer agreement allows purchases of up to 20 million primers per month from a strategic supplier
Two additional ammunition inspection units added, supplementing equipment acquired earlier this year at the Hagerstown, Maryland facility
Separate raw material supply agreement announced; no financial terms, dollar values or contract durations were disclosed
Filing is a Regulation FD disclosure furnishing the November 3, 2026 press release; no financial results were reported
TuHURA Biosciences borrowed an additional $1.5 million on November 2, 2026, under the revolving credit facility from its April 21, 2026 Loan Agreement with Parkview Holdings One LLC. The facility has a maximum availability of $50 million and matures on April 21, 2031, and the company says it will use the funds for general corporate purposes.
Draw of $1,500,000 received and borrowed on November 2, 2026
Revolving facility with Parkview Holdings One LLC has maximum availability of $50 million
Facility matures April 21, 2031; the Loan Agreement was originally entered into April 21, 2026
Filing notes potential conflicts of interest because the lender is an affiliate of the company's largest stockholder
NorthWestern Energy filed a presentation for the EEI Financial Conference in Scottsdale, Arizona, November 8-10, 2026, in which executives will affirm the company's 2026 non-GAAP earnings guidance of $3.68 to $3.83 per diluted share. The filing reports no new financial results and no change to guidance, and the guidance excludes costs related to the pending merger with Black Hills Corp.
2026 non-GAAP EPS guidance of $3.68 to $3.83 per diluted share is affirmed, not changed
Presentation dated November 8, 2026, furnished as Exhibit 99.1 and not deemed filed under Section 18 of the Exchange Act
Presenters are CEO Brian Bird, CFO Crystal Lail, and Travis Meyer, director of corporate development and investor relations
The presentation cites a $3.21 billion five-year capital plan and a Montana final order on the Black Hills merger expected by November 12, 2026
Lazard filed a prospectus supplement covering the possible resale of up to 9,416,817 common shares issued to sellers in its previously announced acquisition of Campbell Lutyens Holdings Limited. The filing is administrative and sets up potential sales of these shares by the selling stockholders, which could add to the number of shares available in the market.
Prospectus supplement under Rule 424(b) filed November 6, 2026, covering up to 9,416,817 shares of common stock
Sullivan & Cromwell LLP opinion on share validity filed as Exhibit 5.1
Data Storage Corporation said director Harold J. Schwartz resigned from its Board of Directors, effective immediately, after notifying the Board on November 4, 2026. The company said the resignation was not due to any disagreement over its operations, policies or practices, and that Mr. Schwartz did not serve on any Board committee.
Harold J. Schwartz resigned as a Board member, effective immediately
Notice to the Board was given on November 4, 2026; the 8-K was dated November 6, 2026
Company states no disagreement with management on operations, policies or practices
Mr. Schwartz previously served as an officer of former subsidiary CloudFirst Technologies Corporation and sat on no Board committee
Santander Holdings USA, Inc. (SHUSA) said it will redeem all 6,000 outstanding shares of its Series H Preferred Stock and the corresponding 6,000,000 depositary shares on December 15, 2026. Depositary shares will be redeemed at $25.00 each, and the redemption price excludes the regular quarterly dividend, which is payable separately on the same date to holders of record on November 30, 2026.
Redemption date: December 15, 2026, covering 6,000 preferred shares and 6,000,000 depositary shares.
Redemption price: $25.00 per depositary share, not including the declared quarterly dividend.
Quarterly dividend: $0.328125 per depositary share, payable December 15, 2026 to holders of record as of November 30, 2026.
Redemption agent: Broadridge Corporate Issuer Solutions, LLC; shares are held through DTC.
BCP Investment Corporation postponed the release of its third quarter 2026 financial results and the related conference call, which were originally scheduled for November 5 and November 6, 2026. The company said the delay gives management more time to finalize financial disclosures, regulatory filings and structural terms tied to a potential strategic initiative, and that there is no assurance this will lead to a definitive agreement or transaction.
Q3 2026 results release and conference call postponed from November 5 and November 6, 2026
Delay tied to finalizing disclosures, regulatory filings and structural terms of a potential strategic initiative
Company states the delay is not related to any accounting, financial or regulatory matters
New call date and dial-in details to be issued by separate press release in the coming days
RPM International's Chairman and CEO Frank C. Sullivan announced on November 6, 2026 that he plans to retire within the next twelve to eighteen months. He will remain in his role until a successor is appointed and is expected to then stay on as Chair of the Board, as the company runs a succession planning process with its Board.
Frank C. Sullivan plans to retire in the next twelve to eighteen months, per the November 6, 2026 filing.
Sullivan has served nearly 25 years as Chairman and CEO and more than 40 years with the company.
He will remain CEO until his successor is appointed and is expected to stay on as Board Chair afterward.
Delta Air Lines completed a public offering of $500 million in 5.500% notes maturing November 6, 2029, on November 6, 2026. The company said it will use part of the proceeds to repay about $391 million of Payroll Support Program loan borrowings, about $70 million of aircraft-secured equipment notes, and, with cash on hand, about $39 million of pass through certificates, with any remainder for general corporate purposes. The filing adds new unsecured debt to the balance sheet while reducing several existing obligations.
Notes: $500 million aggregate principal, 5.500% coupon, maturing November 6, 2029
Interest paid semi-annually on May 6 and November 6, starting May 6, 2027
Proceeds to repay about $391 million Payroll Support Program loan, about $70 million equipment notes, and about $39 million pass through certificates
American Healthcare REIT entered into a new at-the-market equity sales agreement allowing it to sell up to $1.75 billion of common stock through a group of sales agents and forward purchasers. The company terminated its prior program, which had about $170 million left unsold, and says it will use any net proceeds for general corporate purposes, which may include future investments.
Agreement allows sales of common stock with an aggregate gross sales price of up to $1,750,000,000, replacing the prior program dated February 27, 2026.
About $170,134,000 remained unsold under the prior sales agreement when it was terminated.
Agents may receive a commission of up to 2.0% of gross sales price; shares are sold under a shelf registration statement on Form S-3 dated August 12, 2024.
Proceeds would go to the Operating Partnership for general corporate purposes, which may include potential future investments.
Victory Capital filed an 8-K with supplemental disclosures to its proxy statement for the planned acquisition of First Eagle, which it says it made voluntarily to reduce the risk of litigation delaying the deal. Two stockholder lawsuits and a number of demand letters allege the proxy statement was materially incomplete and misleading, and Victory says those claims are without merit. The company states the supplemental disclosures do not change the consideration or the timing of the November 17, 2026 special meeting.
Base purchase price for First Eagle is $7.03 billion, subject to adjustment, including a reduction for First Eagle's funded debt and other debt-like items.
Share consideration is valued at $2 billion based on $116.26 per share and represents 4.9% of Victory's outstanding common stock after issuance.
Two complaints were filed in New York Supreme Court on October 27 and October 28, 2026, and plaintiffs seek to enjoin the deal or seek rescission or damages.
The special meeting of Victory stockholders is scheduled for November 17, 2026, and the board still recommends voting FOR the proposals.
Silgan signed a consent to its credit agreement with Wells Fargo as administrative agent, letting lenders designate a new subsidiary, Silgan Metal Packaging LLC, as an unrestricted subsidiary. The change supports the planned contribution of several container and closure businesses to that entity under the October 17, 2026 Transaction Agreement. The filing gives no financial results or deal value, so the near-term effect on shareholders is not quantified here.
Consent to Amended and Restated Credit Agreement dated November 6, 2026, with Wells Fargo Bank, National Association, as Administrative Agent
Silgan Metal Packaging LLC (MetalCo) to be designated an Unrestricted Subsidiary, releasing it as a guarantor under the credit agreement
Business Contribution tied to the Transaction Agreement dated October 17, 2026 with A-VL Holdco, LP
If the MetalCo Transactions do not close, MetalCo and its subsidiaries will cease to be Unrestricted Subsidiaries
Hyatt Hotels filed a Regulation FD disclosure on lock-up restrictions covering its Class A and Class B shares. Based on current agreements, 14,685,256 restricted shares held by Pritzker family stockholders will be available for public sale from November 5, 2026 through November 4, 2027, which could add supply to the stock market.
14,685,256 restricted shares held by Pritzker family stockholders may be sold from November 5, 2026 to November 4, 2027
2,270,395 additional restricted Class B shares held by other 2007 Stockholders' Agreement parties are available for sale at any time, subject to Company rights of first refusal
An additional 2,678 restricted shares are not subject to lock-up restrictions
Nexentis Technologies Inc. effected a 1-for-5 reverse stock split of its common stock, under authority approved by stockholders on April 30, 2026. The split took effect at 4:15 p.m. Eastern Time on November 6, 2026, and the stock will trade on a split-adjusted basis on the Nasdaq Capital Market from November 9, 2026, under the existing symbol NXTS. The company said the split is intended to raise the per-share price and bid price to regain compliance with Nasdaq continued listing requirements.
Every 5 outstanding shares converted into 1 share; per-share exercise prices and option and warrant share counts adjusted proportionately
Outstanding shares to fall from approximately 2.9 million to approximately 600 thousand, per the press release
Trading begins on a split-adjusted basis November 9, 2026, under new CUSIP 80512Q709
Authorized common stock unchanged at 495,000,000 shares; fractional shares rounded up to the next whole share
D. Boral Acquisition I Corp., a British Virgin Islands blank-check company, disclosed that director Benjamin Piggott resigned from its board on September 23, 2026, saying the decision was not related to any disagreement with the company. The board appointed Kevin McGurn and Luisa Ingargiola to its Audit and Compensation Committees, with McGurn also named Compensation Committee chair. The changes are board administration and do not include any financial or operational figures.
Benjamin Piggott resigned from the board, effective with notice to the board on September 23, 2026
Kevin McGurn appointed to the Audit Committee and named Compensation Committee chair, effective September 23, 2026
Luisa Ingargiola appointed to the Compensation Committee, effective September 23, 2026
McGurn reassigned from Class I to Class II director; his term expires at the second annual shareholder meeting
Fractyl Health's board increased its size from nine to ten and appointed Michael Wartell as an independent Class III director effective November 2, 2026. Wartell will receive $40,000 per month in cash compensation under a director agreement, with a minimum of three months guaranteed unless he resigns.
Michael Wartell appointed effective November 2, 2026; term expires at the 2027 annual meeting
Cash compensation of $40,000 per month, payable monthly in advance, with a three-month minimum unless he resigns
Additional $3,000 for each day Board commitments exceed four hours outside normal Board duties
Wartell has not been appointed to any Board committee and will not join the Non-Employee Director Compensation Policy
Cantor Fitzgerald Income Trust, Inc. declared its October 2026 distributions on November 6, 2026, at an annual rate of 5.00% of net asset value per share class. The filing lists gross distributions for each share class, with Class I shares at $0.089263 and Class D shares at $0.089221, payable on or about November 6, 2026 to holders of record as of October 31, 2026. The filing states that some or all of the cash distributions may be paid from sources other than cash flow from operations.
Gross distribution per Class I share: $0.089263; Class D: $0.089221; Class S and Class T: $0.089178
Annual rate: 5.00% of net asset value per share class
Record date: October 31, 2026; payment date: on or about November 6, 2026
Some or all cash distributions may be paid from sources other than cash flow from operations
Energy Transfer LP priced $2.7 billion of senior notes in three equal $900 million tranches, due 2032, 2037 and 2057, with coupons of 5.450%, 5.900% and 6.550%. The offering is expected to settle on November 20, 2026, and the net proceeds of about $2.68 billion (before offering expenses) are intended to refinance existing debt, including commercial paper and revolving credit facility borrowings, and for general partnership purposes.
Three $900 million tranches: 5.450% notes due 2032, 5.900% notes due 2037 and 6.550% notes due 2057.
Prices to the public were 99.972%, 99.719% and 99.862% of face value, respectively.
Expected settlement date is November 20, 2026, subject to customary closing conditions.
Net proceeds of about $2.68 billion will refinance existing indebtedness and fund general partnership purposes; several underwriters' affiliates are lenders under the revolving credit facility and may receive a share of the repayment.
Enova International said subsidiary OnDeck Asset Securitization IV, LLC intends to offer $500,251,000 of Series 2026-2 fixed rate asset-backed notes in a private securitization backed by small business loans originated or purchased by its subsidiary ODK Capital, LLC. Closing is anticipated on or about November 13, 2026, subject to market and customary conditions, so the offering may not be completed as contemplated or at all. The notes will not be obligations of or guaranteed by Enova or OnDeck, and OnDeck expects to use substantially all proceeds for loan purchases from affiliates and general corporate purposes.
Four classes total $500,251,000: Class A $190,095,000 at 5.81%, Class B $118,744,000 at 6.15%, Class C $100,050,000 at 6.73%, Class D $91,362,000 at 8.57%.
Anticipated Kroll Bond Rating Agency ratings range from AA (sf) for Class A to BB- (sf) for Class D.
Notes are offered only to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S, and are not registered under the Securities Act.
Legal final payment date is December 19, 2033; the company announced the offering on November 3, 2026.
Molina Healthcare said senior management will reaffirm its 2026 full-year GAAP diluted EPS guidance of at least $2.38 and adjusted diluted EPS guidance of at least $5.25 at UBS's Global Healthcare Conference on November 9, 2026. The filing reaffirms existing guidance rather than changing it, so shareholders get no new numbers, but it confirms the company's outlook as of early November.
Reaffirmed 2026 full-year GAAP diluted EPS guidance of at least $2.38
Reaffirmed 2026 full-year adjusted diluted EPS guidance of at least $5.25
Remarks at UBS conference on November 9, 2026 available by webcast at 10:15 a.m. Eastern Time, with a 30-day replay
Roku completed its merger with Fox Corporation on November 6, 2026, becoming a wholly owned subsidiary of FOX. Roku stockholders received $95.30 in cash and 0.9799 of a share of FOX Class A common stock per share, and trading of Roku stock on Nasdaq will halt.
The merger became effective on November 6, 2026, resulting in a change in control.
Stockholders are entitled to $95.30 in cash and 0.9799 of a FOX Class A common stock share per share.
Roku requested the removal of its Class A common stock from listing on Nasdaq.
Roku terminated its existing credit agreement dated September 16, 2024.
ACRES Commercial Realty Corp. entered into a Seventh Amendment to its Master Repurchase and Securities Contract Agreement with Morgan Stanley Mortgage Capital Holdings, which extends the agreement to November 2027 and modifies certain financial covenants in the related guaranty. The filing describes a routine financing amendment and does not disclose a borrowing amount, pricing, or fee figures beyond a reference to an unspecified Extension Fee.
Amendment dated November 2, 2026 extends the Morgan Stanley agreement to November 2027.
Company, as guarantor, agreed to amend certain financial covenants in its guaranty to Morgan Stanley.
Subsidiary ACRES Real Estate SPE 10, LLC is the seller; payment of an Extension Fee was due on or before November 3, 2026, amount not stated in the filing.
Zenas BioPharma filed a new prospectus supplement for an at-the-market offering of up to $200 million in common stock through Jefferies LLC, and ended the earlier program, under which it had sold about $153.2 million of shares with about $46.8 million unsold. The filing is a routine share-sale mechanism, and any sales would dilute existing shareholders, though the filing does not state whether or when any shares will be sold.
New prospectus supplement filed November 6, 2026, for up to $200,000,000 of common stock under the October 8, 2025 Sales Agreement with Jefferies LLC
Prior program terminated: about $153.2 million sold and about $46.8 million unsold at filing date
Shares to be offered under the existing Form S-3ASR registration statement, which became automatically effective upon filing
Ropes & Gray LLP legal opinion filed as Exhibit 5.1
On November 5, 2026, the Public Service Commission of Wisconsin approved rate changes in rate cases filed in April 2026 by Wisconsin Electric Power Company, Wisconsin Gas LLC and Wisconsin Public Service Corporation. The presentation slides attached to the filing list an authorized return on equity of 9.50% and an equity ratio of 53.0%, and say a final written order is expected before year-end.
PSCW approved rate changes on November 5, 2026 for Wisconsin Electric, Wisconsin Gas and Wisconsin Public Service
Authorized return on equity of 9.50% and equity ratio of 53.0%
Earnings sharing: no sharing on the first 15 basis points above the allowed ROE, 50/50 on the next 25 basis points, and 100% to customers beyond 40 basis points
NB Bancorp, Inc., the holding company of Needham Bank, issued $100 million of 7.50% fixed-to-floating subordinated notes due 2036 to institutional investors on November 6, 2026, at 100% of principal. The company estimates net proceeds of approximately $98,265,004.75 and plans to use them for general corporate purposes, including at least $30 million to increase the bank's Tier 1 capital, and the notes are intended to count as Tier 2 capital.
$100 million principal, maturing November 15, 2036, issued at 100% of principal in a private placement
Fixed rate of 7.50% until November 15, 2031, then resets quarterly to three-month SOFR plus 305 basis points
Estimated net proceeds of approximately $98,265,004.75; at least $30 million to be contributed to Needham Bank
Notes rated BBB- by Kroll Bond Rating Agency; Piper Sandler & Co. was sole placement agent
AMETEK director Gretchen W. McClain notified the company on November 6, 2026, that she is resigning from the Board of Directors effective immediately. The filing says the resignation is for personal reasons and involves no controversy or disagreement with the company.
Resignation notified to AMETEK on November 6, 2026, effective immediately
Filing states the resignation is for personal reasons
Filing states there is no controversy or disagreement with the company
Travelers increased its Board from nine to ten directors and elected Lesley Goldwasser, Vice Chairman of GreensLedge Capital Markets, effective November 4, 2026. She also joined the Compensation, Investment and Capital Markets and Nominating and Governance Committees, and will receive standard non-employee director compensation. The filing describes a routine board addition with no financial results or changes to company operations.
Board expanded from nine to ten directors effective November 4, 2026
Lesley Goldwasser elected director, serving until the next annual shareholder election
Goldwasser appointed to the Compensation, Investment and Capital Markets and Nominating and Governance Committees
Goldwasser was a Managing Partner of GreensLedge from 2013 until Raymond James acquired it in March 2026
GATX Corporation agreed under an underwriting agreement dated November 2, 2026 to sell $300 million of 5.950% Senior Notes due 2036, and issued the notes to the underwriters on November 6, 2026. The filing describes a debt issuance rather than a change in operations, so its main significance for shareholders is the added long-term borrowing.
Principal amount: $300 million of 5.950% Senior Notes due 2036
Underwriting agreement dated November 2, 2026, with BofA Securities, Citigroup Global Markets and Morgan Stanley & Co. as representatives
Notes issued and delivered to underwriters against payment on November 6, 2026
Sold under shelf registration statement on Form S-3 (Registration No. 333-286436)
Class B Director Donald Harrison notified Space Exploration Technologies Corp. on November 4, 2026, that he is resigning from the Board of Directors, effective immediately. The company said the resignation was not due to any disagreement on its operations, policies, or practices, so the filing reports no dispute behind the departure.
Donald Harrison, a Class B Director, gave notice of resignation on November 4, 2026.
The resignation is effective immediately.
The filing states it was not due to any disagreement with the company on operations, policies, or practices.
Diversified Energy Company approved a new Diversified Gas & Oil Corporation Deferred Compensation Plan, effective January 1, 2027, letting named executive officers and certain U.S. non-employee directors defer pay. The filing describes a company match of 100% on base salary and short-term incentive deferrals up to 7% of pay above the Code Section 401(a)(17) limit, but gives no cost estimate or financial results.
Plan approved by the Compensation Committee on November 3, 2026, effective January 1, 2027
Participants may defer up to 80% of base salary, short-term incentive and long-term cash awards, and up to 100% of RSUs, PSUs and director retainers
Company match of 100% on base salary and short-term incentive deferrals, up to 7% of pay above the 401(a)(17) limit; no match on other deferrals
FiEE said its Kyoto, Japan art exhibition and related auction, held October 23 to 25, 2026, generated about $2.9 million in aggregate artwork transaction value and about $1.3 million in service revenue for the company. The filing presents the event as an early step in its art-technology business model, and it does not give a prior-period comparison or any updated financial guidance.
Exhibition ran October 23 to 25, 2026, in partnership with the Museum of Kyoto; the auction was held October 23, 2026.
The auction drew nearly 400 participants online and in person.
Aggregate artwork transaction value was about $2.9 million, which the company says is artwork sales and not its revenue.
FiEE generated about $1.3 million in service revenue from the auction and plans regular art appreciation and networking events.
aTyr Pharma filed a prospectus supplement allowing it to sell common stock worth up to $79,994,251 from time to time under an existing open market sale agreement with Jefferies LLC. The filing sets up potential share issuance that could dilute existing shareholders, though the filing does not state how much stock has been or will be sold.
Maximum aggregate offering price of up to $79,994,251 under the Sales Agreement with Jefferies LLC, dated April 22, 2022, as amended December 23, 2024
Offering is made under Form S-3 shelf registration (File No. 333-289360), filed August 7, 2025 and declared effective August 18, 2025
Cooley LLP legal opinion on the legality of the shares filed as Exhibit 5.1
Knight-Swift's board declared a quarterly cash dividend of $0.20 per share, payable December 21, 2026 to holders of record on December 7, 2026. The board also appointed Richard Howard as a director effective November 4, 2026, filling a newly added seat, which adds a director with prior truck financing and leadership experience.
Quarterly cash dividend of $0.20 per common share, declared November 5, 2026
Record date December 7, 2026; payment expected December 21, 2026
Richard Howard appointed to the board effective immediately on November 4, 2026, to serve until the 2027 annual meeting
Howard received 357 shares of restricted stock and was named to the Finance and Nominating and Corporate Governance committees
Dutch Bros said Chief Legal Officer Victoria Tullett will retire in 2027 and move to a Strategic Advisor role effective January 1, 2027, ending her executive officer status. Kira Druyan, formerly Senior Vice President, Deputy General Counsel and Chief Ethics & Compliance Officer at Starbucks, will succeed her as Chief Legal Officer on or about January 1, 2027. The filing describes a planned executive transition and does not include financial results or guidance.
Victoria Tullett notified the company on November 4, 2026, of her decision to retire in 2027.
Tullett becomes Strategic Advisor effective January 1, 2027, and will no longer be an executive officer.
Kira Druyan is appointed Incoming Chief Legal Officer, reporting to CEO Christine Barone, and will assume the role on or about January 1, 2027.
Tullett is eligible for severance under the company's Amended and Restated Severance and Change in Control Plan, as described in the March 31, 2026 proxy statement.
DarioHealth Corp. said its board appointed John R. Palumbo as Chairman effective immediately, on November 3, 2026, following a recommendation from the Nominating Committee. He replaces Yoav Shaked, who remains on the board as a member. The filing does not state any financial results or reasons for the change.
Appointment made November 3, 2026, on the recommendation of the Nominating Committee
John R. Palumbo became Chairman of the Board effective immediately
Yoav Shaked steps down as Chairman but will continue to serve as a board member
Realty Income's Compensation and Talent Committee adopted the 2026 Promote Award Plan on November 3, 2026. The plan lets employees, including named executive officers, earn bonuses tied to incentive allocations from certain investment funds and joint ventures the company manages, with bonus pools capped at 40% of each allocation. The filing gives no dollar amounts for awards, so shareholder cost cannot be sized from this document.
Plan adopted November 3, 2026 by the Compensation and Talent Committee
Bonus pools may not exceed 40% of the incentive allocation for each measurement period
Executive bonuses paid in stock-based awards; 50% vests at grant and 50% after one year, unless the Committee decides otherwise
Filing includes the plan and form of RSU award agreement as Exhibits 10.1 and 10.2
On November 5, 2026, the sponsor 21Shares US LLC gave notice to House of Doge Inc. terminating, effective immediately, a Support Services Agreement covering research, data, operational support and marketing services for the trust. The sponsor said it elected to terminate the agreement under its terms. The filing does not state a reason or name a replacement provider, and the terms of the services transition are not described.
Notice given November 5, 2026; termination effective immediately
Agreement is between the sponsor, 21Shares AG and House of Doge Inc.
Services covered include research, data, operational support and marketing for the trust
Filing states the sponsor elected to terminate under the agreement's terms
Bowman Consulting Group Ltd. completed its merger with Prive Parent, Inc., an affiliate of Bernhard Capital Partners, on November 6, 2026, and is now a wholly owned subsidiary of Parent. Each outstanding share was converted into the right to receive $43.00 in cash, so public shareholders no longer hold stock in the company. The company's common stock is being removed from Nasdaq and deregistered, ending its public reporting.
Each share of common stock converted into the right to receive $43.00 in cash, without interest.
The merger was funded by equity commitments from BCP funds and a debt financing commitment, per the filing.
Nasdaq was asked to suspend trading and withdraw the listing before the market opened on November 6, 2026.
Six directors, including founder Gary Bowman, resigned at the Effective Time; Mark D. Spender, Jonathan Parnell, Joe Boyer and Gary Bowman became directors of the Surviving Corporation.
BranchOut Food Inc. disclosed that its Compensation Committee approved a $40,000 cash bonus for Chief Financial Officer John Dalfonsi on November 2, 2026. The filing is an administrative compensation disclosure with no change in officers and no reported effect on company results.
Compensation Committee approved a $40,000 cash bonus to CFO John Dalfonsi on November 2, 2026.
No change in officer or director roles is reported in the filing.
The 8-K was signed by CEO Eric Healy on November 6, 2026, and includes an XBRL cover page exhibit.
Public Storage Operating Company, a subsidiary of Public Storage, completed a $500 million offering of 5.600% Senior Notes due November 15, 2036, guaranteed by Public Storage. The filing describes new long-term unsecured debt with covenants limiting secured and unsecured borrowing and requiring unencumbered assets of at least 125% of unsecured indebtedness.
Principal amount of $500 million; interest at 5.600% per year, accruing from November 6, 2026
Interest payable semi-annually on May 15 and November 15, starting May 15, 2027; maturity November 15, 2036
Notes are unsecured and rank equally with existing and future unsecured debt of the issuer; redeemable at a make-whole price, or at 100% of principal from August 15, 2036
Offering made under a Form S-3 shelf registration; prospectus supplement dated October 29, 2026
Janus Living, Inc. closed a registered underwritten public offering of 30,187,500 Class A-1 common shares on November 6, 2026, including the underwriters' full exercise of their option to buy 3,937,500 additional shares. The filing does not state the offering price or the proceeds, and the issuance adds shares that will dilute existing holders' ownership.
Offering closed November 6, 2026 with 30,187,500 Class A-1 common shares, $0.01 par value
Underwriters exercised their option in full for 3,937,500 additional shares
Underwriting Agreement dated November 4, 2026 with BofA Securities, J.P. Morgan, Wells Fargo and Goldman Sachs as representatives
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.